Related Experiment Video
Updated: Jul 11, 2026
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
Pharmaceutical Research - Academic Collaborations: An Insider's Perspective
1Department of Pharmacology, School of Medicine, University of Virginia, Charlottesville, VA 22903, United States.
ACS Medicinal Chemistry Letters
|May 14, 2025
Summary
Enabling chemistry technologies can significantly reduce drug development timelines and costs. Industry and academic collaborations are key to implementing these innovations effectively.
Area of Science:
- Pharmaceutical Sciences
- Chemical Engineering
- Drug Discovery
Background:
- The pharmaceutical industry faces constant pressure to develop new therapeutics faster and more affordably.
- Traditional drug development processes can be lengthy and expensive, impacting market entry and accessibility.
Purpose of the Study:
- To explore the potential of enabling chemistry technology in reducing drug development cycle times.
- To highlight how these technologies can decrease the cost of goods for new therapeutics.
- To emphasize the role of industry-academic collaborations in advancing these innovations.
Main Methods:
- Review and discussion of enabling chemistry technologies.
- Analysis of their impact on process efficiency and cost reduction.
- Case examples of industry and academic partnerships.
Main Results:
- Enabling chemistry technologies offer substantial improvements in reducing cycle times.
- Implementation of these technologies leads to a significant decrease in the cost of goods.
- Collaborative efforts accelerate the development and adoption of novel chemical solutions.
Conclusions:
- Adoption of enabling chemistry technology is crucial for pharmaceutical innovation.
- Strategic collaborations between industry and academia are vital for successful implementation.
- These advancements promise more cost-effective and timely therapeutic development.
More Related Videos
Related Concept Videos
01:26Drug Discovery: Overview
7.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.2K
01:11Clinical Trials: Overview
2.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.5K
01:19Pharmacovigilance
755
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
755
01:28Preclinical Development: Overview
4.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.1K
01:28Biopharmaceutics and Pharmacokinetics: Overview
1.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.8K
01:26Drug Administration and Therapy Phases: Overview
391
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
391